Vitamin D and Inflammatory Bowel Disease

Vitamins and Hormones

Volumn 86, Issue , 2011, Pages 367-377

  Ardizzone, Sandro ^a   Cassinotti, Andrea ^a   Bevilacqua, Maurizio ^a   Clerici, Mario ^b   Porro, Gabriele Bianchi ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Crohn's disease; Ulcerative colitis; Vitamin D

Indexed keywords

VITAMIN D;

ANIMAL; BOOK; ENTERITIS; HUMAN; IMMUNE SYSTEM; IMMUNOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; VITAMIN D DEFICIENCY;

ANIMALS; HUMANS; IMMUNE SYSTEM; INFLAMMATORY BOWEL DISEASES; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 79952651967     PISSN: 00836729     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-386960-9.00016-2     Document Type: Book

References (48)

1. Adorini L., Penna G. Control of autoimmune diseases by the vitamin D endocrine system. Nat. Clin. Pract. Rheumatol. 2008, 4:404-412.
2. Ardizzone S., Bianchi Porro G. Inflammatory bowel disease: New insights into pathogenesis and treatment. J. Intern. Med. 2002, 252:4675-4696.
3. Ardizzone S., Cassinotti A., Trabattoni D., et al. Immunomodulatory effects of 1,25-dihydroxyvitamin d3 on th1/th2 cytokines in inflammatory bowel disease: An in vitro study. Int. J. Immunopathol. Pharmacol. 2009, 22:63-71.
4. Baumgart D.C., Carding S.R. Inflammatory bowel disease: Cause and immunobiology. Lancet 2007, 369:1627-1640.
5. Cantorna M.T. Vitamin D and autoimmunity: Is vitamin D status an environmental factor affecting autoimmune disease prevalence?. Proc. Soc. Exp. Biol. Med. 2000, 223:230-233.
6. Cantorna M.T. Vitamin D and its role in immunology: Multiple sclerosis, and inflammatory bowel disease. Prog. Biophys. Mol. Biol. 2006, 92:60-64.
7. Cantorna M.T. Micronutrients and the immune system. Mechanisms underlying the effect of vitamin D on the immune system. Proc. Nutr. Soc. 2010, 69:286-289.
8. Cantorna M.T., Mahon B.D. Mounting evidence for vitamin D as an environmental factor affecting autoimmune disease prevalence. Exp. Biol. Med. 2004, 229:1136-1142.
9. Cantorna M.T., Munsick C., Bemiss C., et al. 1,25-Dihydroxycholecalciferol prevents and ameliorates symptoms of experimental murine inflammatory bowel disease. J. Nutr. 2000, 130:2648-2652.
10. Chapuy M.C., Preziosi P., Maarner M., et al. Prevalence of vitamin D insufficiency in an adult normal population. Osteoporos. Int. 1997, 7:439-443.
11. Cooney R., Baker J., Brain O., et al. NOD2 stimulation induces autophagy in dendritic cells influencing bacterial handling and antigen presentation. Nat. Med. 2010, 16:90-97.
12. Coulombe F., Divangahi M., Veyrier F., et al. Increased NOD2-mediated recognition of N-glycolyl muramyl dipeptide. J. Exp. Med. 2009, 206:1709-1716.
13. Daniel C., Sartory N.A., Zahn N., et al. Immune modulatory treatment of TNBS colitis with calcitriol is associated with a change of a Th1/Th17 to a Th2 and regulatory T cell profile. J. Pharmacol. Exp. Ther. 2008, 324:23-33.
14. Feller M., Huwiler K., Stephan R., et al. Mycobacterium avium subspecies paratuberculosis and Crohn's disease: A systematic review and meta-analysis. Lancet Infect. Dis. 2007, 7:607-613.
15. Fiocchi C. What is "physiological" intestinal inflammation and how does it differ from "pathological" inflammation?. Inflamm. Bowel Dis. 2008, 14(Suppl. 2):S77-S78.
16. Froicu M., Cantorna M.T. Vitamin D and the vitamin D receptor are critical for control of the innate immune response to colonic injury. BMC Immunol. 2007, 8:5.
17. Froicu M., Weaver V., Wynn T.A., et al. A crucial role for the vitamin D receptor in experimental inflammatory bowel diseases. Mol. Endocrinol. 2003, 17:2386-2392.
18. Froicu M., Zhu Y., Cantorna M.T. Vitamin D receptor is required to control gastrointestinal immunity in IL-10 knockout mice. Immunology 2006, 117:310-318.
19. Ginde A.A., Liu M.C., Camargo C.A., et al. Demographic differences and trends of vitamin D insufficiency in the US population, 2988-2004. Arch. Intern. Med. 2009, 169:626-632.
20. Gombart A.F., Borregaard N., Koeffler H.P. Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly upregulated in myeloid cells by 1,25-dihydroxyvitamin D3. FASEB J. 2005, 19:1067-1077.
21. Hampe J., Franke A., Rosenstiel P., et al. A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat. Genet. 2007, 39:207-211.
22. Hewison M. Vitamin D and the immune system: New perspectives on an old theme. Endocrinol. Metab. Clin. N. Am. 2010, 39:365-379.
23. Holick M.F. Vitamin D deficiency. N. Engl. J. Med. 2007, 357:26-81.
24. Hugot J.-P., Chamaillard M., Zouali H., et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001, 411:599-603.
25. Inohara N., Ogura Y., Fontalba A., et al. Host recognition of bacterial muramyl dipeptide mediated through NOD2. J. Biol. Chem. 2003, 2278:5509-5512.
26. Jørgensen S.P., Agnholt J., Glerup H., et al. Clinical trial: Vitamin D3 treatment in Crohn's disease-A randomized double-blind placebo-controlled study. Aliment Pharmacol. Ther. 2010, 32:377-383.
27. Kong J., Zhang Z., Mush M.W., et al. Novel role of the vitamin D receptor in maintaining the integrity of the intestinal mucosal barrier. Am. J. Physiol. Gastrointest. Liver Physiol. 2008, 294(1):G208-G216.
28. Lai Y., Gallo R.L. AMPed up immunity: How antimicrobial peptides have multiple roles in immune defense. Trends Immunol. 2009, 30:131-141.
29. Lapaquette P., Glasser A.-L., Huett A., Xavier R.J., Darfeuille-Michaud A. Crohn's disease-associated adherent-invasive E. coli are selectively favoured by impaired autophagy to replicate intracellularly. Cell. Microbiol. 2010, 12:99-113.
30. Laverny G., Penna G., Vetrano S., et al. Efficacy of a potent and safe vitamin D receptor agonist for the treatment of inflammatory bowel disease. Immunol. Lett. 2010, 131:49-58.
31. Liu P.T., Stenger S., Li H., et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006, 311:1770-1773.
32. Miheller P., Muzes G., Hritz I., et al. Comparison of the effects of 1,25 dihydroxyvitamin D and 25 hydroxyvitamin D on bone pathology and disease activity in Crohn's disease patients. Inflamm. Bowel Dis. 2009, 15:1656-1662.
33. Mizushima N., Kuma A., Kobayashi Y., et al. Mouse Apg16L, a novel WD-repeat protein, targets to the autophagic isolation membrane with the Apg12-Apg5 conjugate. J. Cell Sci. 2003, 116:1679-1688.
34. Namgung R., Mimouni F., Campaigne B.N., et al. Low bone mineral content in summer-born compared with winterborn infants. J. Pediatr. Gastroenterol. Nutr. 1992, 15:285-288.
35. Namgung R., Tsang R.C., Specker B.L., et al. Low bone mineral content and high serum osteocalcin and 1,25-dihydroxyvitamin D in summer- versus winter-born newborn infants: An early fetal effect?. J. Pediatr. Gastroenterol. Nutr. 1994, 19:220-227.
36. Parkes M., Barrett J.C., Prescott N.J., et al. Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility. Nat. Genet. 2007, 39:830-832.
37. Podolsky D.K. Inflammatory bowel disease. N. Engl. J. Med. 1991, 325:928-937.
38. Rioux J.D., Xavier R.J., Taylor K.D., et al. Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat. Genet. 2007, 39:596-604.
39. Scaldaferri F., Fiocchi C. Inflammatory bowel disease: Progress and current concepts of etiopathogenesis. J. Dig. Dis. 2007, 8:171-178.
40. Stio M., Treves C., Martinesi M., et al. Effect of anti-TNF therapy and vitamin D derivatives on the proliferation of peripheral blood mononuclear cells in Crohn's disease. Dig. Dis. Sci. 2004, 49(2):328-335.
41. Szodoray P., Nakken B., Gaal J. The complex role of vitamin D in autoimmune diseases. Scand. J. Immunol. 2008, 68:261-269.
42. Travassos L.H., Carneiro L.A.M., Ramjeet M., et al. Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry. Nat. Immunol. 2010, 11:55-62.
43. Verway M., Behr M.A., White J.H. Vitamin D, NOD2, autophgy and Crohn's disease. Expert Rev. Clin. Immunol. 2010, 6:505-508.
44. Wang T.-T., Nestel F.P., Bourdeau V., et al. Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J. Immunol. 2004, 173:2909-2912.
45. Wang T.-T., Dabbas B., Laperriere D., et al. Direct and indirect induction by 1,25-dihydroxyvitamin D3 of the NOD2/CARD15-defensin b2 innate immune pathway defective in Crohn disease. J. Biol. Chem. 2010, 285:2227-2231.
46. Weber G., Heilborn J.D., Chamorro Jimenez C.I., et al. Vitamin D induces the antimicrobial protein hCAP18 in human skin. J. Invest. Dermatol. 2005, 124:1080-1082.
47. Yuk J.-M., Shin D.-M., Lee H.-M., et al. Vitamin D3 induces autophagy in human monocytes/macrophages via cathelicidin. Cell Host Microbe 2009, 6:231-243.
48. Zhu Y., Mahon B.D., Froicu M., et al. Calcium and 1alpha,25-dihydroxyvitamin D3 target the TNF-alpha pathway to suppress experimental inflammatory bowel disease. Eur. J. Immunol. 2005, 35:217-224.